4.8 Article

Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 116, 期 6, 页码 1675-1685

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI26856

关键词

-

资金

  1. NIAID NIH HHS [AI07244-22, AI09484, R01 AI009484, T32 AI007244] Funding Source: Medline
  2. NINDS NIH HHS [NS048866-01, R21 NS048866] Funding Source: Medline
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, R37AI009484, R01AI009484] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048866] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Failure to clear persistent viral infections results from the early loss of T cell activity. A pertinent question is whether the immune response is programmed to fail or if nonresponsive T cells can specifically be fixed to eliminate infection. Although evidence indicates that T cell expansion is permanently programmed during the initial priming events, the mechanisms that determine the acquisition of T cell function are less clear. Herein we show that in contrast to expansion, the functional programming of T cell effector and memory responses in vivo in mice is not hardwired during priming but is alterable and responsive to continuous instruction from the antigenic environment. As a direct consequence, dysfunctional T cells can be functionally reactivated during persistent infection even after an initial program of inactivation has been instituted. We also show that early therapeutic reductions in viral replication facilitate the preservation of antiviral CD4(+) T cell activity, enabling the long-term control of viral replication. Thus, dysfunctional antiviral T cells can regain activity, providing a basis for future therapeutic strategies to treat persistent viral infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据